Top

Published in:

Open Access 01-12-2015 | Review

How foot-and-mouth disease virus receptor mediates foot-and-mouth disease virus infection

Authors: Guangxiang Wang, Yanhua Wang, Youjun Shang, Zhidong Zhang, Xiangtao Liu

Published in: Virology Journal | Issue 1/2015

Abstract

This study reviews the FMDV receptor-binding domain, integrin receptors, and heparan sulfate receptors to provide references for studies regarding the mechanisms underlying FMDV infection.

Remond M, Kaiser C, Lebreton F. Diagnosis and screening of foot-and-mouth disease. Comp Immunol Microbiol Infect Dis. 2002;25:309–20.CrossRefPubMed

Grubman MJ, Baxt B. Foot-and-mouth disease. Clin Microbiol Rev. 2004;17:465–93.CrossRefPubMedCentralPubMed

Thomson GR, Vosloo W, Bastos AD. Foot and mouth disease in wildlife. Virus Res. 2003;91:145–61.CrossRefPubMed

Sumption K, Rweyemamu M, Wint W. Incidence and distribution of foot-and-mouth disease in Asia, Africa and South America, combining expert opinion, official disease information and livestock populations to assist risk assessment. Transbound Emerg Dis. 2008;55:5–13.CrossRefPubMed

Gibbs P. The foot-and-mouth disease epidemic of 2001 in the UK: implications for the USA and the “war on terror”. J Vet Med Educ. 2003;30:121–32.CrossRefPubMed

Norkin LC. Virus receptors: implications for pathogenesis and the design of antiviral agents. Clin Microbiol Rev. 1995;8:293–315.PubMedCentralPubMed

Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T, King A, et al. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature. 1993;362:566–8.CrossRefPubMed

Forss S, Strebel K, Beck E, Schaller H. Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res. 1984;12:6587–601.CrossRefPubMedCentralPubMed

Palmenberg AC. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol. 1990;44:603–23.CrossRefPubMed

10.

Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature. 1982;298:30–3.CrossRefPubMed

11.

Verdaguer N, Mateu MG, Andreu D, Giralt E, Domingo E, Fita I. Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. EMBO J. 1995;14:1690–6.PubMedCentralPubMed

12.

Parry N, Fox G, Rowlands D, Brown F, Fry E, Acharya R, et al. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature. 1990;347:569–72.CrossRefPubMed

13.

Aggarwal N, Barnett PV. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species. J Gen Virol. 2002;83:775–82.PubMed

14.

Dicara D, Burman A, Clark S, Berryman S, Howard MJ, Hart IR, et al. Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness. J Virol. 2008;82:1537–46.CrossRefPubMedCentralPubMed

15.

Escarmís C, Perales C, Domingo E. Biological effect of Muller's Ratchet: distant capsid site can affect picornavirus protein processing. J Virol. 2009;83:6748–56.CrossRefPubMedCentralPubMed

16.

Martínez MA, Carrillo C, González-Candelas F, Moya A, Domingo E, Sobrino F. Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J Virol. 1991;65:3954–7.PubMedCentralPubMed

17.

Martínez MA, Verdaguer N, Mateu MG, Domingo E. Evolution subverting essentiality: dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. Proc Natl Acad Sci U S A. 1997;94:6798–802.CrossRefPubMedCentralPubMed

18.

Ruiz-Jarabo CM, Sevilla N, Dávila M, Gómez-Mariano G, Baranowski E, Domingo E. Antigenic properties and population stability of a foot-and-mouth disease virus with an altered Arg-Gly-Asp receptor-recognition motif. J Gen Virol. 1999;80:1899–909.PubMed

19.

Gutiérrez-Rivas M, Pulido MR, Baranowski E, Sobrino F, Sáiz M. Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context. J Gen Virol. 2008;89:2531–9.CrossRefPubMed

20.

Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, et al. Comparative genomics of foot-and-mouth disease virus. J Virol. 2005;79:6487–504.CrossRefPubMedCentralPubMed

21.

González-Amaro R, Sánchez-Madrid F. Cell adhesion molecules: selectins and integrins. Crit Rev Immunol. 1999;19:389–429.PubMed

22.

O'Donnell V, LaRocco M, Duque H, Baxt B. Analysis of foot-and-mouth disease virus internalization events in cultured cells. J Virol. 2005;79:8506–18.CrossRefPubMedCentralPubMed

23.

Hynes RO. Cell adhesion: old and new questions. Trends Cell Biol. 1999;15:33–7.CrossRef

24.

Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697–715.CrossRefPubMed

25.

Berinstein A, Roivainen M, Hovi T, Mason PW, Baxt B. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit Bin-ding and infection of foot-and-mouth disease virus to cultured cells. J Virol. 1995;69:2664–6.PubMedCentralPubMed

26.

Jackson T, Sheppard D, Denyer M, Blakemore W, King AM. The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus. J Virol. 2000;74:4949–56.CrossRefPubMedCentralPubMed

27.

Jackson T, Mould AP, Sheppard D, King AM. Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus. J Virol. 2002;76:935–41.CrossRefPubMedCentralPubMed

28.

Jackson T, Clark S, Berryman S, Burman A, Cambier S, Mu D, et al. Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol. 2004;78:4533–40.CrossRefPubMedCentralPubMed

29.

Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T. Specificity of the VP1 GH loop of foot-and-mouth disease virus for alphav integrins. J Virol. 2006;80:9798–810.CrossRefPubMedCentralPubMed

30.

Monaghan P, Gold S, Simpson J, Zhang Z, Weinreb PH, Violette SM, et al. The alpha(v)beta6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J Gen Virol. 2005;86:2769–80.CrossRefPubMed

31.

Neff S, Baxt B. The ability of integrin alpha(v)beta(3) to function as a receptor for foot-and-mouth disease virus is not dependent on the presence of complete subunit cytoplasmic domains. J Virol. 2001;75:527–32.CrossRefPubMedCentralPubMed

32.

Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673–87.CrossRefPubMed

33.

Breuss JM, Gillett N, Lu L, Sheppard D, Pytela R. Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues. J Histochem Cytochem. 1993;41:1521–7.CrossRefPubMed

34.

Huang XZ, Wu JF, Cass D, Erle DJ, Corry D, Young SG, et al. Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J Cell Biol. 1996;133:921–8.CrossRefPubMed

35.

Brown JK, McAleese SM, Thornton EM, Pate JA, Schock A, Macrae AI, et al. Integrin-alphavbeta6, a putative receptor for foot -and -mouth disease virus, is constitutively expressed in ruminant airways. J Histochem Cytochem. 2006;54:807–16.CrossRefPubMed

36.

Du J, Chang H, Gao S, Xue S, Cong G, Shao J, et al. Molecular characterization and expression analysis of porcine integrins alphavbeta3, alphavbeta6 and alphavbeta8 that are potentially involved in FMDV infection. Mol Cell Probes. 2010;24:256–65.CrossRefPubMed

37.

Monaghan P, Simpson J, Murphy C, Durand S, Quan M, Alexandersen S. Use of confocal immunofluorescence microscopy to localize viral nonstructural proteins and potential sites of replication in pigs experimentally infected with foot-and-mouthdisease virus. J Virol. 2005;79:6410–8.CrossRefPubMedCentralPubMed

38.

Miller LC, Blakemore W, Sheppard D, Atakilit A, King AM, Jackson T. Role of the cytoplasmic domain of the beta-subunit of integrin alpha(v)beta6 in infection by foot-and-mouth disease virus. J Virol. 2001;75:4158–64.CrossRefPubMedCentralPubMed

39.

Berryman S, Clark S, Monaghan P, Jackson T. Early events in integrin alphavbeta6-mediat-ed cell entry of foot-and-mouth disease virus. J Virol. 2005;79:8519–34.CrossRefPubMedCentralPubMed

40.

Duque H, LaRocco M, Golde WT, Baxt B. Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins. J Virol. 2004;78:9773–81.CrossRefPubMedCentralPubMed

41.

Milner R, Edwards G, Streuli C, Ffrench-Constant C. A role in migration for the alpha V beta 1 integrin expressed on oligodendrocyte precursors. J Neurosci. 1996;6:7240–52.

42.

Cambier S, Mu DZ, O'Connell D, Boylen K, Travis W, Liu WH, et al. A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth. Cancer Res. 2000;60:7084–93.PubMed

43.

Fjellbirkeland L, Cambier S, Broaddus VC, Hill A, Brunetta P, Dolganov G, et al. Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue. Am J Pathol. 2003;163:533–42.CrossRefPubMedCentralPubMed

44.

Duque H, Baxt B. Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses. J Virol. 2003;77:2500–11.CrossRefPubMedCentralPubMed

45.

Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, et al. Functions of cell surface heparin sulfate proteoglycans. Ann Rev Biochem. 1999;68:729–77.CrossRefPubMed

46.

Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, et al. Efficient infection of cells in culture by type O Foot-and-Mouth disease virus requires binding to cell surface heparen sulfate. J Virol. 1996;70:5282–7.PubMedCentralPubMed

47.

Baranowski E, Ruiz-Jarabo CM, Sevilla N, Andreu D, Beck E, Domingo E. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J Virol. 2000;74:1641–7.CrossRefPubMedCentralPubMed

48.

Baxt B, Bachrach HL. Early interactions of foot-and-mouth disease virus with cultured cells. Virology. 1980;104:42–55.CrossRefPubMed

49.

Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, et al. The structure and function of a foot-and-mouth disease virus–oligosaccharide receptor complex. EMBO J. 1999;18(3):543–54.CrossRefPubMedCentralPubMed

50.

Han SC, Guo HC, Sun SQ. Three-dimensional structure of foot-and-mouth disease virus and its biological functions. Arch Virol. 2015;160:1–16.CrossRefPubMed

51.

Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F. Cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine -glycine-aspartic acid). J GenVirol. 1989;70:625–37.

52.

Ruiz-Sáenz J, Goez Y, Tabares W, López-Herrera A. Cellular receptors for foot and mouth disease virus. Intervirology. 2009;52:201–12.CrossRefPubMed

53.

O'Donnell V, Larocco M, Baxt B. Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis. J Virol. 2008;82:9075–85.CrossRefPubMedCentralPubMed

54.

Baranowski E, Sevilla N, Verdaguer N, Ruiz-Jarabo CM, Beck E, Domingo E. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J Virol. 1998;72:6362–72.PubMedCentralPubMed

55.

Baxt B, Mason PW. Foot-and-mouth disease virus undergoes restricted replication in macrophage cell cultures following Fc receptor mediated adsorption. Virology. 1995;207:503–9.CrossRefPubMed

56.

Rieder E, Berinstein A, Baxt B, Kang A, Mason PW. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus. Proc Natl Acad Sci U S A. 1996;93:10428–33.CrossRefPubMedCentralPubMed

57.

Zhao Q, Pacheco JM, Mason PW. Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in Animals. J Virol. 2003;77:3269–80.CrossRefPubMedCentralPubMed

Title: How foot-and-mouth disease virus receptor mediates foot-and-mouth disease virus infection
Authors: Guangxiang Wang
Yanhua Wang
Youjun Shang
Zhidong Zhang
Xiangtao Liu
Publication date: 01-12-2015
Publisher: BioMed Central
Published in: Virology Journal / Issue 1/2015
Electronic ISSN: 1743-422X
DOI: https://doi.org/10.1186/s12985-015-0246-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

How foot-and-mouth disease virus receptor mediates foot-and-mouth disease virus infection

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2015

Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia

The M, F and HN genes of genotype VIId Newcastle disease virus are associated with the severe pathological changes in the spleen of chickens

Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection

Pathogenesis of natural and experimental Pseudorabies virus infections in dogs

Serological survey of canine H3N2, pandemic H1N1/09, and human seasonal H3N2 influenza viruses in cats in northern China, 2010–2014

Sequencing and phylogenetic analysis of the gp51 gene from Korean bovine leukemia virus isolates

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page